Panion & Bf Biotech (TPE:1760) FFO


TPE:1760 Panion & Bf Biotech Inc TPE:1760
74 GF Score
Price NT$59.60
GF Value NT$95.99
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Panion & Bf Biotech FFO?

FFO (Funds from operations) only applies to REITs.

TPE:1760
74GF Score
Panion & Bf Biotech Inc TPE:1760
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Panion & Bf Biotech (TPE:1760) Overvalued in 2026?

Based on GuruFocus' analysis, Panion & Bf Biotech stock appears to be undervalued. The current stock price of NT$59.60 is trading 37.9% below its estimated GF Value™ of NT$95.99. GuruFocus considers Panion & Bf Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1760:

  • FFO:
  • GF Value™: NT$95.99 vs. price of NT$59.60 (37.9% below fair value)
  • GF Score™: 74/100 with 4 warning signs

No single metric tells the full story. See the TPE:1760 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Panion & Bf Biotech Business Description

Address No. 3, Park Street, 16th Floor, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company, along with its subsidiaries, is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups: disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan; China, Hong Kong, and Macau; the USA; and Korea. It generates a majority of its revenue from the Taiwan segment. Product-wise the firm generates the majority of its revenue from Pharmaceutical products.
74GF Score

Get the complete analysis for TPE:1760

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$59.60
Price
NT$95.99
GF Value